Instinet to Integrate Nomura U.S. Equity Research into Agency Execution Platform06.16.2016 By John D'Antona Editor, Traders Magazine
Instinet.com -NEW YORK – June 15, 2016 – Instinet Incorporated announced plans to offer U.S. equity research and U.S. research sales services through its agency brokerage platform in the Americas.
U.S. equity research and U.S. research sales personnel currently servicing clients from Nomura Securities International, Inc., will transfer to Instinet, LLC, upon regulatory approval. The new organizational structure will present clients with a focused, boutique-style content offering that is tightly paired with Instinet’s deep liquidity and diverse execution capabilities currently provided to more than 1,000 clients.
“Over the past five years, Nomura has built a high-quality research product in the Americas that’s driven by exceptional talent,” said Jonathan Kellner, CEO of Instinet. “This provides us with a great framework to evolve our equity offering and allows us to partner with our clients more effectively in the investment and alphageneration process. We look forward to the research team joining Instinet and to building this platform together.”
“This change creates a differentiated model that puts the power of our research ideas together with Instinet’s dominant U.S. brand and 45-plus years of best-in-class execution,” said Penn Egbert, Head of Global Markets Research for Nomura in the Americas. “Our clients will benefit from the complementary strengths of the teams, and from a client-focused equities product with scale and reach.” Clients will continue to have seamless access to both Nomura and Instinet’s research offerings globally.
Intraday markets play an important role in banks’ liquidity optimisation strategy.
The collaboration increases access to corporate bond liquidity.
European trading in fixed income instruments is highly fragmented and non-transparent.
Buy-side trading desks are under pressure to adopt more data-driven trade automation.
COVID-19market stress highlighted the potential systemic significance of disorderly corporate bond trading.